Efficacy Of A Pelargonium Sidoides Preparation In Patients With The Common Cold: A Randomized, Double Blind, Placebo-controlled Clinical Trial

Effect Decrease
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 103
Sex Both Genders
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
In adults with cold symptoms for 24-48 hours, supplementation of EPs7630 at 30 drops (1.5mL) thrice daily for up to 10 days and assessed by total symptoms and cold intensity rating scales noted that supplementation was assocatiated with twice the reduction in symptoms than was placebo, and after 10 days 78.8% of persons given the supplement were seen as clinically cured (relative to 31.4% of placebo).